GF
CVS icon

Gries Financial’s CVS Health CVS Stock Holding History

Gries Financial’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,540
Closed -$240K – 302
2025
Q1 		$240K Buy
+3,540
New +$212K 0.05% 241
2024
Q4 		– Sell
-16,557
Closed -$1.04M – 286
2024
Q3 		$1.04M Sell
16,557
-3,493
-17% -$204K 0.19% 120
2024
Q2 		$1.18M Sell
20,050
-4,292
-18% -$268K 0.24% 97
2024
Q1 		$1.94M Buy
24,342
+296
+1% +$22.6K 0.32% 87
2023
Q4 		$1.9M Buy
24,046
+2,268
+10% +$161K 0.42% 67
2023
Q3 		$1.52M Buy
21,778
+1,747
+9% +$124K 0.41% 70
2023
Q2 		$1.38M Buy
20,031
+7,277
+57% +$518K 0.38% 71
2023
Q1 		$948K Buy
+12,754
New +$1.07M 0.28% 86
2021
Q4 		– Sell
-30,521
Closed -$2.59M – 164
2021
Q3 		$2.59M Sell
30,521
-4,754
-13% -$398K 0.81% 31
2021
Q2 		$2.88M Sell
35,275
-243
-0.7% -$19.9K 0.92% 24
2021
Q1 		$2.99M Buy
+35,518
New +$2.59M 0.96% 26

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Gries Financial's CVS Position: Q2 2025 in Review

Gries Financial sold out of CVS Health (CVS) in Q2 2025, closing a stake of 3,540 shares — an estimated $240K sold.

Gries Financial first reported a position in CVS in Q1 2021 and held it in 11 quarters. The position peaked at $2.99M in Q1 2021. 1,759 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Gries Financial reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Gries Financial sold 3,540 CVS Health shares in Q2 2025, an estimated $240K.
  • Gries Financial first reported a position in CVS Health in Q1 2021 and held it in 11 quarters.
  • Gries Financial's CVS Health position peaked at $2.99M in Q1 2021.
  • 1,759 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Gries Financial's 13F filing for Q2 2025, filed 14 Jul 2025.